atc_code
stringlengths 1
7
| atc_description
stringlengths 3
113
| atc_level
int64 1
5
| atc_parent_code
stringlengths 1
5
⌀ | schedule_code
int64 3.67k
3.67k
|
---|---|---|---|---|
V09HA01 | technetium (99mTc) human immunoglobulin | 5 | V09HA | 3,671 |
V09HA02 | technetium (99mTc) exametazime labelled cells | 5 | V09HA | 3,671 |
V09HA03 | technetium (99mTc) antigranulocyte antibody | 5 | V09HA | 3,671 |
V09HA04 | technetium (99mTc) sulesomab | 5 | V09HA | 3,671 |
V09HB | Indium (111In) compounds | 4 | V09H | 3,671 |
V09HB01 | indium (111In) oxinate labelled cells | 5 | V09HB | 3,671 |
V09HB02 | indium (111In) tropolonate labelled cells | 5 | V09HB | 3,671 |
V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection | 4 | V09H | 3,671 |
V09HX01 | gallium (67Ga) citrate | 5 | V09HX | 3,671 |
V09I | TUMOUR DETECTION | 3 | V09 | 3,671 |
V09IA | Technetium (99mTc) compounds | 4 | V09I | 3,671 |
V09IA01 | technetium (99mTc) antiCarcinoEmbryonicAntigen antibody | 5 | V09IA | 3,671 |
V09IA02 | technetium (99mTc) antimelanoma antibody | 5 | V09IA | 3,671 |
V09IA03 | technetium (99mTc) pentavalent succimer | 5 | V09IA | 3,671 |
V09IA04 | technetium (99mTc) votumumab | 5 | V09IA | 3,671 |
V09IA05 | technetium (99mTc) depreotide | 5 | V09IA | 3,671 |
V09IA06 | technetium (99mTc) arcitumomab | 5 | V09IA | 3,671 |
V09IA07 | technetium (99mTc) hynic-octreotide | 5 | V09IA | 3,671 |
V09IA08 | technetium (99mTc) etarfolatide | 5 | V09IA | 3,671 |
V09IA09 | technetium (99mTc) tilmanocept | 5 | V09IA | 3,671 |
V09IA10 | technetium (99mTc) trofolastat chloride | 5 | V09IA | 3,671 |
V09IB | Indium (111In) compounds | 4 | V09I | 3,671 |
V09IB01 | indium (111In) pentetreotide | 5 | V09IB | 3,671 |
V09IB02 | indium (111In) satumomab pendetide | 5 | V09IB | 3,671 |
V09IB03 | indium (111In) antiovariumcarcinoma antibody | 5 | V09IB | 3,671 |
V09IB04 | indium (111In) capromab pendetide | 5 | V09IB | 3,671 |
V09IX | Other diagnostic radiopharmaceuticals for tumour detection | 4 | V09I | 3,671 |
V09IX01 | iobenguane (123I) | 5 | V09IX | 3,671 |
V09IX02 | iobenguane (131I) | 5 | V09IX | 3,671 |
V09IX03 | iodine (125I) CC49-monoclonal antibody | 5 | V09IX | 3,671 |
V09IX04 | fludeoxyglucose (18F) | 5 | V09IX | 3,671 |
V09IX05 | fluorodopa (18F) | 5 | V09IX | 3,671 |
V09IX06 | sodium fluoride (18F) | 5 | V09IX | 3,671 |
V09IX07 | fluorocholine (18F) | 5 | V09IX | 3,671 |
V09IX08 | fluoroethylcholine (18F) | 5 | V09IX | 3,671 |
V09IX09 | gallium (68Ga) edotreotide | 5 | V09IX | 3,671 |
V09IX10 | fluoroethyl-L-tyrosine (18F) | 5 | V09IX | 3,671 |
V09IX11 | fluoroestradiol (18F) | 5 | V09IX | 3,671 |
V09IX12 | fluciclovine (18F) | 5 | V09IX | 3,671 |
V09IX13 | methionine (11C) | 5 | V09IX | 3,671 |
V09IX14 | gallium (68Ga) gozetotide | 5 | V09IX | 3,671 |
V09IX15 | copper (64Cu) dotatate | 5 | V09IX | 3,671 |
V09IX16 | piflufolastat (18F) | 5 | V09IX | 3,671 |
V09IX17 | PSMA-1007 (18F) | 5 | V09IX | 3,671 |
V09IX18 | flotufolastat (18F) | 5 | V09IX | 3,671 |
V09X | OTHER DIAGNOSTIC RADIOPHARMACEUTICALS | 3 | V09 | 3,671 |
V09XA | Iodine (131I) compounds | 4 | V09X | 3,671 |
V09XA01 | iodine (131I) norcholesterol | 5 | V09XA | 3,671 |
V09XA02 | iodocholesterol (131I) | 5 | V09XA | 3,671 |
V09XA03 | iodine (131I) human albumin | 5 | V09XA | 3,671 |
V09XX | Various diagnostic radiopharmaceuticals | 4 | V09X | 3,671 |
V09XX01 | cobalt (57Co) cyanocobalamine | 5 | V09XX | 3,671 |
V09XX02 | cobalt (58Co) cyanocobalamine | 5 | V09XX | 3,671 |
V09XX03 | selenium (75Se) norcholesterol | 5 | V09XX | 3,671 |
V09XX04 | ferric (59Fe) citrate | 5 | V09XX | 3,671 |
V10 | THERAPEUTIC RADIOPHARMACEUTICALS | 2 | V | 3,671 |
V10A | ANTIINFLAMMATORY AGENTS | 3 | V10 | 3,671 |
V10AA | Yttrium (90Y) compounds | 4 | V10A | 3,671 |
V10AA01 | yttrium (90Y) citrate colloid | 5 | V10AA | 3,671 |
V10AA02 | yttrium (90Y) ferrihydroxide colloid | 5 | V10AA | 3,671 |
V10AA03 | yttrium (90Y) silicate colloid | 5 | V10AA | 3,671 |
V10AB | HOMEOPATHIC PRODUCTS WITH THERAPEUTIC CLAIMS | 4 | V10A | 3,671 |
V10AX | Other antiinflammatory therapeutic radiopharmaceuticals | 4 | V10A | 3,671 |
V10AX01 | phosphorous (32P) chromicphosphate colloid | 5 | V10AX | 3,671 |
V10AX02 | samarium (153Sm) hydroxyapatite colloid | 5 | V10AX | 3,671 |
V10AX03 | dysprosium (165Dy) colloid | 5 | V10AX | 3,671 |
V10AX04 | erbium (169Er) citrate colloid | 5 | V10AX | 3,671 |
V10AX05 | rhenium (186Re) sulfide colloid | 5 | V10AX | 3,671 |
V10AX06 | gold (198Au) colloidal | 5 | V10AX | 3,671 |
V10B | PAIN PALLIATION (BONE SEEKING AGENTS) | 3 | V10 | 3,671 |
V10BX | Various pain palliation radiopharmaceuticals | 4 | V10B | 3,671 |
V10BX01 | strontium (89Sr) chloride | 5 | V10BX | 3,671 |
V10BX02 | samarium (153Sm) lexidronam | 5 | V10BX | 3,671 |
V10BX03 | rhenium (186Re) etidronic acid | 5 | V10BX | 3,671 |
V10X | OTHER THERAPEUTIC RADIOPHARMACEUTICALS | 3 | V10 | 3,671 |
V10XA | Iodine (131I) compounds | 4 | V10X | 3,671 |
V10XA01 | sodium iodide (131I) | 5 | V10XA | 3,671 |
V10XA02 | iobenguane (131I) | 5 | V10XA | 3,671 |
V10XA03 | iodine (131I) omburtamab | 5 | V10XA | 3,671 |
V10XA04 | iodine (131I) apamistamab | 5 | V10XA | 3,671 |
V10XA53 | tositumomab/iodine (131I) tositumomab | 5 | V10XA | 3,671 |
V10XX | Various therapeutic radiopharmaceuticals | 4 | V10X | 3,671 |
V10XX01 | sodium phosphate (32P) | 5 | V10XX | 3,671 |
V10XX02 | ibritumomab tiuxetan (90Y) | 5 | V10XX | 3,671 |
V10XX03 | radium (223Ra) dichloride | 5 | V10XX | 3,671 |
V10XX04 | lutetium (177Lu) oxodotreotide | 5 | V10XX | 3,671 |
V10XX05 | lutetium (177Lu) vipivotide tetraxetan | 5 | V10XX | 3,671 |
V20 | SURGICAL DRESSINGS | 2 | V | 3,671 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.